CXCR6 also represents an attractive therapeutic target in ICI colitis as it has a direct role in the genesis of tumour metastasis by determining increased ease with which tumour cells acquire the ability to migrate, invade and metastasize and conversely reduce this potential when there is a silencing of this molecule [84]. The gene discussed is CXCR6; the disease is colitis.